Search For "grabody platform"
ABL Bio Receives Upfront Payment for License, Research and Collaboration A
Updated : 5 months, 2 weeks ago IST
Seoul [South Korea], December 26: ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity inv
Read More